References
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.
Wilson KFM, Oh D, Calvin N, Michael M, Ramsay R, Heriot A. Immune checkpoint blockade in lower gastrointestinal cancers: A systematic review. Ann Surg Oncol. Epub 28 May 2021. doi: https://doi.org/10.1245/s10434-021-10192-x.
Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182–91.
Andre T, Shiu K-K, Kim TW, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study. J Clin Oncol. 2020;38(18 Suppl):LBA4.
Chalabi M, Fanchi LF, Dijkstra KK, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. Apr 2020;26(4):566–76.
Funding
No Grant supports or financial relationships were associated with this study from any funding agencies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wilson, K., Heriot, A. ASO Author Reflections: Immunotherapy in Rectal Cancer Illusion or Nirvana. Ann Surg Oncol 28, 7474–7475 (2021). https://doi.org/10.1245/s10434-021-10262-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10262-0